Pennington, NJ, United States of America

Derek J Norris

USPTO Granted Patents = 31 


 

Average Co-Inventor Count = 6.1

ph-index = 10

Forward Citations = 436(Granted Patents)


Location History:

  • Trenton, NJ (US) (1999 - 2014)
  • Hopewell, NJ (US) (2016)
  • Pennington, NJ (US) (2006 - 2024)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents

Title: **Derek J. Norris: Innovator in Pharmaceutical Research**

Introduction

Derek J. Norris, located in Pennington, NJ, is a prolific inventor known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 30 patents, Norris has been at the forefront of developing innovative solutions aimed at treating serious health conditions, particularly proliferative disorders like cancer.

Latest Patents

Norris's recent patents reflect his dedication to advancing medical science. One notable invention is related to **NLRP3 modulators**, which are compounds designed to address the modulation of NLRP3. These compounds, as outlined in the patented formula, hold potential as medicaments for the treatment of various proliferative disorders, including cancer. Another important patent focuses on **uracil derivatives as Mer-AXL inhibitors**. This invention encompasses compounds that inhibit Mer-Axl and expands pharmaceutical methodologies for treating disorders linked to dysregulated apoptosis, including cancer.

Career Highlights

Throughout his career, Derek J. Norris has been associated with prominent companies such as Bristol-Myers Squibb Company and Innate Tumor Immunity, Inc. His work in these organizations has played a pivotal role in the research and development of groundbreaking therapeutic agents. Norris's expertise and innovative approaches have contributed to significant advancements in cancer treatment modalities.

Collaborations

Collaboration is key in the field of research and development, and Norris has worked closely with talented professionals such as Ping Chen and Ashvinikumar V. Gavai. Together, they have fostered a creative environment that encourages the exchange of ideas, ultimately leading to the successful development of innovative therapies.

Conclusion

Derek J. Norris's impressive portfolio and collaborative efforts underscore his commitment to advancing pharmaceutical science. His work has not only enriched the medical community's understanding of treatment options but also opened new avenues for therapeutic innovation. As he continues to explore new horizons in research, Norris remains a leading figure in the quest to combat proliferative disorders and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…